A detailed history of Schroder Investment Management Group transactions in Abbott Laboratories stock. As of the latest transaction made, Schroder Investment Management Group holds 1,014,944 shares of ABT stock, worth $115 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,014,944
Previous 982,976 3.25%
Holding current value
$115 Million
Previous $112 Million 5.61%
% of portfolio
0.12%
Previous 0.13%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$100.73 - $112.44 $3.22 Million - $3.59 Million
31,968 Added 3.25%
1,014,944 $105 Million
Q1 2024

May 14, 2024

BUY
$109.52 - $120.96 $2.94 Million - $3.25 Million
26,842 Added 2.81%
982,976 $112 Million
Q4 2023

Feb 13, 2024

SELL
$90.19 - $110.4 $8.77 Million - $10.7 Million
-97,201 Reduced 9.23%
956,134 $105 Million
Q3 2023

Nov 14, 2023

SELL
$95.53 - $114.62 $7.09 Million - $8.51 Million
-74,230 Reduced 6.58%
1,053,335 $102 Million
Q2 2023

Aug 11, 2023

BUY
$100.78 - $112.29 $10.3 Million - $11.5 Million
102,522 Added 10.0%
1,127,565 $123 Million
Q1 2023

May 11, 2023

SELL
$96.86 - $114.01 $14.2 Million - $16.7 Million
-146,640 Reduced 12.52%
1,025,043 $104 Million
Q4 2022

Feb 10, 2023

SELL
$95.06 - $111.52 $3.49 Million - $4.09 Million
-36,695 Reduced 3.04%
1,171,683 $129 Million
Q3 2022

Nov 10, 2022

SELL
$96.76 - $112.03 $52.7 Million - $61 Million
-544,553 Reduced 31.07%
1,208,378 $117 Million
Q2 2022

Aug 11, 2022

BUY
$102.07 - $123.37 $23.4 Million - $28.3 Million
229,686 Added 15.08%
1,752,931 $190 Million
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $17.8 Million - $21.8 Million
156,547 Added 11.45%
1,523,245 $183 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $21.7 Million - $26.6 Million
188,095 Added 15.96%
1,366,698 $192 Million
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $24.2 Million - $26.8 Million
-207,405 Reduced 14.96%
1,178,603 $139 Million
Q2 2021

Aug 13, 2021

SELL
$105.79 - $124.53 $71.4 Million - $84 Million
-674,843 Reduced 32.75%
1,386,008 $161 Million
Q1 2021

May 17, 2021

SELL
$108.84 - $128.23 $4.53 Million - $5.34 Million
-41,647 Reduced 1.98%
2,060,851 $247 Million
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $41.7 Million - $45.4 Million
396,784 Added 23.26%
2,102,498 $230 Million
Q3 2020

Nov 13, 2020

BUY
$91.64 - $111.29 $32.6 Million - $39.6 Million
356,121 Added 26.39%
1,705,714 $182 Million
Q2 2020

Aug 13, 2020

BUY
$76.57 - $98.0 $21.6 Million - $27.6 Million
281,721 Added 26.38%
1,349,593 $123 Million
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $1.76 Million - $2.58 Million
-28,052 Reduced 2.56%
1,067,872 $88.3 Million
Q4 2019

Feb 11, 2020

BUY
$78.51 - $87.4 $15.1 Million - $16.8 Million
192,220 Added 21.27%
1,095,924 $95.2 Million
Q3 2019

Nov 12, 2019

BUY
$81.84 - $88.74 $14.9 Million - $16.1 Million
181,930 Added 25.21%
903,704 $74 Million
Q2 2019

Aug 08, 2019

BUY
$72.88 - $85.0 $2.02 Million - $2.35 Million
27,688 Added 3.99%
721,774 $60.7 Million
Q1 2019

May 14, 2019

BUY
$66.22 - $80.06 $36.2 Million - $43.7 Million
546,080 Added 368.96%
694,086 $55.5 Million
Q4 2018

Feb 14, 2019

BUY
$65.56 - $74.27 $1.21 Million - $1.37 Million
18,387 Added 14.19%
148,006 $10.7 Million
Q3 2018

Nov 13, 2018

SELL
$60.81 - $73.36 $250,841 - $302,610
-4,125 Reduced 3.08%
129,619 $9.51 Million
Q2 2018

Aug 13, 2018

BUY
$57.57 - $63.54 $3.26 Million - $3.6 Million
56,582 Added 73.33%
133,744 $8.19 Million
Q1 2018

May 11, 2018

BUY
$56.27 - $63.62 $28,585 - $32,318
508 Added 0.66%
77,162 $4.62 Million
Q4 2017

Feb 09, 2018

SELL
$53.68 - $57.47 $459,930 - $492,402
-8,568 Reduced 10.05%
76,654 $4.38 Million
Q3 2017

Nov 09, 2017

BUY
$48.06 - $53.64 $4.1 Million - $4.57 Million
85,222
85,222 $4.57 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.